CD68 and cervical carcinoma: Diverse immune cell types including CD20+ B cells, CD3+ T cells, CD56+ natural killer (NK) cells, and CD68+ macrophages and immune markers PD-L1 were detected in different proportions of cervical carcinoma (57), and these cellular and molecular indicators are typically associated with patient’ survival (58).